Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE) - ANVISA Registration 80003610614

Access comprehensive regulatory information for 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610614 and manufactured by INOVA DIAGNOSTICS, INC. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 1 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
1 Competitors
1 Recent Registrations
80003610614
Registration Details
ANVISA Registration Number: 80003610614
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

80003610614

25351462167202497

02004662000165

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Feb 17, 2025

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE)"